Sha Fei (沙菲)沙菲
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 天津药物研究院药业有限责任公司Chinese legal name: 天津药物研究院药业有限责任公司
主要成分Active Ingredients
- 丁丙诺啡Dingbing Nuofei
药物知识说明
丁丙诺啡是一种在国家药监局注册认定的药品。标注生产企业为天津药物研究院药业有限责任公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为：天津药物研究院药业有限责任公司Chinese legal name: 天津药物研究院药业有限责任公司、天津药物研究院药业有限责任公司Chinese legal name: 天津药物研究院药业有限责任公司、天津药物研究院药业有限责任公司Chinese legal name: 天津药物研究院药业有限责任公司。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 沙菲) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 天津药物研究院药业有限责任公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 天津药物研究院药业有限责任公司Chinese legal name: 天津药物研究院药业有限责任公司, 天津药物研究院药业有限责任公司Chinese legal name: 天津药物研究院药业有限责任公司, 天津药物研究院药业有限责任公司Chinese legal name: 天津药物研究院药业有限责任公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 沙菲Recorded Chinese name: 沙菲
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 1ml:0.15mg1 mL:0.15 mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 天津药物研究院药业有限责任公司Chinese legal name: 天津药物研究院药业有限责任公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H12020275
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H12020275
Manufacturer
Chinese legal name: 天津药物研究院药业有限责任公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H12020275
生产企业
天津药物研究院药业有限责任公司(国产)
适应症
本品用于各类手术后疼痛、癌症疼痛、烧伤后疼痛、脉管炎引起的肢痛及心绞痛和其他内脏痛。为强效镇痛药。
用法用量
肌肉注射，一次0.15～0.3mg，可每隔6～8小时或按需注射。疗效不佳时可适当增加用量。
不良反应
头晕，嗜睡，恶心呕吐，出汗，头痛，皮疹。
禁忌
对本品有过敏史，重症肝损伤，脑部损害，意识模糊及颅内压升高患者禁用。六岁以下儿童，孕妇哺乳期妇女以及轻微疼痛或疼痛原因不明者不宜使用。
注意事项
1. 本品有一定依赖性，戒断症状较轻，因此存在有滥用的可能，故按Ⅰ类精神药品管理，使用时应遵医嘱。2. 呼吸机能低下或紊乱者、已接受其他中枢神经抑制剂治疗者和高龄与虚弱者慎用。3. 本品与受体亲和力高，常规剂量拮抗剂如纳洛酮，对已引起的呼吸抑制无用，推荐使用呼吸兴奋剂(如多沙普仑)。
贮藏
密封
规格
1ml:0.15mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.